Cargando…

MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein

Chemotherapy resistance is a major obstacle to the effective treatment of patients with gastric cancer (GC). Mounting evidence has indicated that the dysregulation of microRNAs (miRNAs) is associated with the sensitivity of cancer cells to chemotherapy. However, the mechanisms underlying miRNA-media...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Xiaoli, Gao, Mengru, Ahmed, Yaser, Gao, Min, Liu, Wenbo, Zhang, Yiyin, Xie, Xiaoque, Zhao, Qihong, Wang, Hua, Gu, Kangsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607034/ https://www.ncbi.nlm.nih.gov/pubmed/31423228 http://dx.doi.org/10.3892/ol.2019.10496

Ejemplares similares

MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells
por: Xie, Xiaoque, et al.
Publicado: (2019)

MicroRNA-200c reverses drug resistance of human gastric cancer cells by targeting regulation of the NER-ERCC3/4 pathway
por: Li, Min, et al.
Publicado: (2019)

MicroRNA-200c as a prognostic and sensitivity marker for platinum chemotherapy in advanced gastric cancer
por: Li, Min, et al.
Publicado: (2017)

MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2
por: Feng, Qiong, et al.
Publicado: (2017)

MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2
por: Feng, Qiong, et al.
Publicado: (2021)

Suppressor of Zeste 12 homolog RNA interference inhibits retinoblastoma cell invasion
por: ZHOU, MIN, et al.
Publicado: (2014)

Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
por: Hibino, S, et al.
Publicado: (2014)

miR-338-5p-ZEB2 axis in Diagnostic, Therapeutic Predictive and Prognostic Value of Gastric Cancer
por: Wei, Xiaoli, et al.
Publicado: (2021)

Correlation between miR-138-5p expression and efficacy of platinum-based chemotherapy in advanced gastric cancer patients
por: Ning, Jie, et al.
Publicado: (2020)

MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling
por: Xia, Jin-tang, et al.
Publicado: (2014)

Overexpression of suppressor of zest 12 is associated with cervical node metastasis and unfavorable prognosis in tongue squamous cell carcinoma
por: Hu, Huijun, et al.
Publicado: (2017)

Oxaliplatin-Based Regimen is Superior to Cisplatin-Based Regimen in Tumour Remission as First-line Chemotherapy for Advanced Gastric Cancer: A Meta-Analysis
por: Zhang, Fei, et al.
Publicado: (2019)

Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation
por: Sun, Si, et al.
Publicado: (2018)

MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2
por: Ma, De-Ning, et al.
Publicado: (2016)

MicroRNA-362 Inhibits Cell Proliferation and Invasion by Directly Targeting SIX1 in Colorectal Cancer
por: Wan, Jin'e, et al.
Publicado: (2019)

MicroRNA-362-3p Inhibits Migration and Invasion via Targeting BCAP31 in Cervical Cancer
por: Yang, Shuya, et al.
Publicado: (2020)

Circular RNA_ANKIB1 accelerates chemo-resistance of osteosarcoma via binding microRNA-26b-5p and modulating enhancer of zeste homolog 2
por: Tang, JinShan, et al.
Publicado: (2022)

MicroRNA-217 acts as a tumor suppressor and correlates with the chemoresistance of cervical carcinoma to cisplatin
por: Yin, Zhaojun, et al.
Publicado: (2019)

Involvement of enhancer of zeste homolog 2 in cisplatin-resistance in ovarian cancer cells by interacting with several genes
por: WANG, HUALI, et al.
Publicado: (2015)

MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma
por: Huang, Sheng-Dong, et al.
Publicado: (2012)

The MicroRNA-217 Functions as a Potential Tumor Suppressor in Gastric Cancer by Targeting GPC5
por: Wang, Hui, et al.
Publicado: (2015)

MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells
por: Zangouei, Amir Sadra, et al.
Publicado: (2021)

MicroRNA-506-3p inhibits colorectal cancer cell proliferation through targeting enhancer of zeste homologue 2
por: Ai, Liang, et al.
Publicado: (2021)

MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin [Retraction]
Publicado: (2023)

MicroRNA-362-5p promotes the proliferation and inhibits apoptosis of trophoblast cells via targeting glutathione-disulfide reductase
por: Zhang, Cuihua, et al.
Publicado: (2021)

miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer
por: Cao, Shujun, et al.
Publicado: (2021)

Clinicopathological Analysis of Expression of Enhancer of Zeste Homologue 2 in Canine Mammary Carcinoma
por: Ren, Xiaoli, et al.
Publicado: (2022)

MicroRNA-217 Functions as a Tumour Suppressor Gene and Correlates with Cell Resistance to Cisplatin in Lung Cancer
por: Guo, Junhua, et al.
Publicado: (2014)

MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin [Expression of Concern]
Publicado: (2022)

MicroRNA-362 negatively and positively regulates SMAD4 expression in TGF-β/SMAD signaling to suppress cell migration and invasion
por: Cheng, Han Ping, et al.
Publicado: (2021)

MicroRNA-31 Function as a Suppressor Was Regulated by Epigenetic Mechanisms in Gastric Cancer
por: Wei, Jun, et al.
Publicado: (2017)

MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma
por: Wang, Dan, et al.
Publicado: (2018)

Serum microRNAs as potential new biomarkers for cisplatin resistance in gastric cancer patients
por: Jin, Lei, et al.
Publicado: (2020)

Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma
por: Kang, Wei, et al.
Publicado: (2015)

MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer
por: Xie, Meng, et al.
Publicado: (2017)

MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer
por: Liu, Xin, et al.
Publicado: (2018)

MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer
por: Sandoval-Bórquez, Alejandra, et al.
Publicado: (2017)

MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation
por: Zhang, Zhen, et al.
Publicado: (2019)

Answer to the question 2 from page 362
Publicado: (2012)

PSAT362 Hypothyroidism Associated Colonic Rupture
por: Seetharaman, Karthik, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0de734n6qqmufr7l3m4lrhdqes